Uh-oh! This study is no longer available.
Moderate to Severe Atopic Dermatitis (Eczema)
PMG Research of Rocky Mount
18 or older
A research study is evaluating the effects of an investigational medication combined with a topical treatment for moderate to severe atopic dermatitis (eczema).
This research study may be an option if you:
• Have been diagnosed with eczema for at least one year
• Have eczema covering at least 10% of your body (Use the palm of your hand to measure 1%)
• Have experienced an inadequate response to topical treatments, corticosteroids or DUPIXENT® (dupilumab)
• Do not have other inflammatory skin conditions other than eczema
Other criteria apply. Please make sure to discuss with a member of our research staff to ensure this study is a good fit for you.
Qualified participants will receive all study-related care and study medication at no cost.
Patient Commitment Duration
Approximately 8 months
Financial compensation may be provided for time and travel expenses.
Number of visits in study
Approximately 10 clinic visits and 2 phone calls